Stanford Mobile Health 2012

Vinay Gidwaney, DailyFeats

Co-founder & Chief Product Officer, DailyFeats

Vinay Gidwaney is a co-founder and Chief Product Officer at DailyFeats.

We face challenges that threaten the foundations of our society. We eat too much junk food. We watch too much junk TV. We buy too much junk. These challenges define our future. At stake is our health, our wealth, our emotional well-being, and the strength of our families and communities. We need to change how we live. We have two beliefs: the first is that change starts with small actions, simple positive choices that people make every day. The second is that to a create a movement for change, we need the involvement of organizations with strong voices. Together, we can create the change our society needs, starting from the smallest actions and working upwards.

DailyFeats helps people reach their goals through small, positive steps. Available free at dailyfeats.com for web and iPhone, DailyFeats celebrates small but significant actions, or “feats,” that contribute to people’s goals for health and well-being. DailyFeats members earn points for those actions, share them with friends, and redeem their points for rewards or donations. DailyFeats’ purpose is to make positive action part of daily life, motivating people to realize the potential of every day.

Vinay Gidwaney was the CTO and Co-founder of Control-F1 which grew into an industry leader in the field of Support Automation. Control-F1 grew to attract over 85 global enterprise customers. Gidwaney started the company shortly after high school. In December of 2005, Control-F1 was acquired by CA, one of the world’s largest software companies with over $3.5B in sales.

In early 2008, Gidwaney was invited to be a visiting researcher in the Synthetic Neurobiology Group at MIT Media Lab. Under the leadership of Dr. Ed Boyden, Vinay is helping to invent novel devices to control neuronal circuits for the treatment of neurological disorders.

Since 2005, Gidwaney has been a Director of and a primary investor in Neurosilicon. Neurosilicon develops novel brain computing interfaces to expand the scientific understanding of the human brain, to revolutionize and improve the effectiveness of drug discovery, and to develop therapeutic technologies for neurological disorders.

In 2002, Gidwaney was a winner of the prestigious MIT Technology Review Top 100 Innovators under 35 award.

Gidwaney has spoken extensively at conferences in the United States and India about the role of technology in healthcare. He has also published articles in publications such as the MIT Technology Review. In 2010, he was recognized as an INK Fellow in association with TED.

Links for Vinay

DailyFeats
@vgidwaney
LinkedIn